Latham & Watkins represented the placement agents in the offering. UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault successfully defended Pretium Resources Inc. in a national class proceeding challenging the disclosure of an adverse opinion received in the course of a public...
You must be a Standard 1 Year member to access this content.
Morrison Foerster advised Unity Software Inc. on the deal, while Latham & Watkins advised ironSource. Unity Software Inc. (NYSE: U), the world’s leading platform for creating...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Pearl Cohen Zedek Latzer Baratz represented HUB Cyber Security (Israel) Limited in the transaction. Loeb & Loeb and Sullivan & Worcester advised...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Goldfarb Seligman & Co. represented Itamar Medical in the transaction. Cooley and Gornitzky & Co. advised ZOLL Medical. Itamar™ Medical Ltd. (Nasdaq...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig represented Memic, while Foley & Lardner represented MedTech. Latham & Watkins represented the placement agents. Memic Innovative Surgery Ltd., a medical device company dedicated...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alpha Tau in the transaction, while Winston & Strawn represented the placement agent. Alpha Tau Medical Limited, the developer of the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Alpha Healthcare Acquisition Corp. on the deal. Covington & Burling LLP advised Humacyte, Inc. on the deal.Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC)...
You must be a Standard 1 Year member to access this content.
